Table 3 Estimated changes (with 95% confidence interval a. ) in use of oral antidiabetic products following the 2006 five-year chronic medication prescriptions promotion strategy
Intercept | Baseline trend | Level change | Trend change | Absolute change (1 year later) | Relative change (1 year later) | Absolute change (3 years later) | Relative change (3 years later) | |
|---|---|---|---|---|---|---|---|---|
Rate of chronic medication prescriptions for diabetes b. | 0.0100 | 0.0080 (0.00069, 0.0091) | 0.0312 (0.0119, 0.0505) | -0.0046 (-0.0063, -0.0029) | 1.28% (-0.68%, 3.24%) | 6.08% (-3.62%, 15.78%) | -2.38% (-4.98%, 0.22%) | -8.65% (-17.35%, 0.05%) |
Share of prescriptions filled at community pharmacies c. | 0.0200 | 0.0063 (0.0053, 0.0073) | 0.0024 (0.0005, 0.0043) | 0.97% (0.22%, 1.73%) | 5.49% (0.79%, 10.19%) | 2.92% (0.66%, 5.19%) | 12.82% (1.66%, 23.98%) | |
Share of reimbursed expenditures accounted by community pharmacies d. | 0.0173 | 0.0063 (0.0047, 0.0079) | 0.002965 (0.0002, 0.0057) | 1.19% (0.08%, 2.30%) | 6.80% (-0.45%, 14.05%) | 3.56% (0.23%, 6.89%) | 15.83% (-1.35%, 33.02%) |